DrugDashboards
← Home
Manufacturing facility

Fresenius Kabi USA, LLC

A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.

Country
United States
Registered address
3159 Staley Road, Grand Island, New York (NY) 14072, United States (USA)
Operations here
analysismanufacture
FDA identifiers
FEI 3001833549 · DUNS 840771732

FDA inspection history

Outcomes of closed FDA inspections at this site (drug and biologic program areas).

  • VAIDrug Quality Assurance2023-10-13
  • VAIDrug Quality Assurance2019-08-12
  • NAIBioresearch Monitoring2017-03-30
  • VAIDrug Quality Assurance2017-03-30
  • VAIDrug Quality Assurance2017-02-01
  • VAIDrug Quality Assurance2016-02-04
  • VAIDrug Quality Assurance2014-10-24
  • OAIDrug Quality Assurance2013-01-11
  • VAIDrug Quality Assurance2011-08-29
  • OAIDrug Quality Assurance2011-07-08
  • VAIDrug Quality Assurance2010-01-13
  • VAIDrug Quality Assurance2009-09-17
  • NAIDrug Quality Assurance2009-03-05
  • NAIDrug Quality Assurance2008-10-31

Drugs this plant is listed as making

71 distinct drugs across 139 products name this site in their FDA label.

Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.